• No results found

Effect of preoperative immunonutrition on complications after salvage surgery in head and neck cancer

N/A
N/A
Protected

Academic year: 2020

Share "Effect of preoperative immunonutrition on complications after salvage surgery in head and neck cancer"

Copied!
9
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Socio-demographic and medical characteristics
Table 2 Effects of immunonutrition on postoperative complications and multivariate analysis
Table 3 Number and grading of complications according to the Buzby [27] and Dindo [28] classifications
Fig. 1 Length of hospital stay. Box plot comparing length ofhospital stay between the group that received immunonutritionbefore salvage surgery and the control group (p < 0.001)

References

Related documents

: High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients. Cell Communication

To evaluate the impact of preoperative anemia and perioperative blood transfusion (PBT) on disease free (DFS) and overall survival (OS) of patients with head and neck squamous

Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.. Head

Study population: The study population consisted of all Danish patients referred for treatment of squamous cell carcinoma of the larynx, pharynx, oral cavity, or neck nodes

Conclusions: Among women undergoing breast cancer-related surgery, preoperative concern about PONV varies by prior history of PONV and motion sickness and by ethnicity.. (2018)

The role of image-guided surveillance as compared with planned neck dissection in the treatment of patients with squamous-cell carcinoma of the head and neck who have advanced

HNC: head and neck cancer; HNSCC: head and neck squamous cell carcinoma; lncRNAs: long noncoding RNAs; HOTAIR: HOX antisense intergenic RNA; PRC2: polycomb repressive complex

Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.